457_582
2026-02-02 Sung, Jae Jun
1151_1315
1324_2057
2066_2883
2900_3045
3063_3664
3673_3968
3985_4060
4078_4366
4375_4974
4983_5287
5304_5402
5420_5929
In particular, the company plans to enroll up to 80 patients in the urothelial carcinoma study to validate anticancer efficacy on a larger scale
6094_6789